GCLLX
Price
$14.87
Change
+$1.25 (+9.18%)
Updated
Apr 9 closing price
Net Assets
351.88M
RWMFX
Price
$59.75
Change
+$4.29 (+7.74%)
Updated
Apr 9 closing price
Net Assets
180.96B
Ad is loading...

GCLLX vs RWMFX

Header iconGCLLX vs RWMFX Comparison
Open Charts GCLLX vs RWMFXBanner chart's image
Goldman Sachs Enh Core EqFund-ClassC
Price$14.87
Change+$1.25 (+9.18%)
VolumeN/A
Net Assets351.88M
American Funds Washington Mutual R5
Price$59.75
Change+$4.29 (+7.74%)
VolumeN/A
Net Assets180.96B
GCLLX vs RWMFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GCLLX vs. RWMFX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCLLX is a Buy and RWMFX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RWMFX has more cash in the bank: 181B vs. GCLLX (352M). RWMFX pays higher dividends than GCLLX: RWMFX (1.53) vs GCLLX (0.00). GCLLX was incepted earlier than RWMFX: GCLLX (17 years) vs RWMFX (23 years). GCLLX (2.00) is less costly to investors than RWMFX (0.31). GCLLX is a more actively managed with annual turnover of: 79.00 vs. RWMFX (31.00). RWMFX has a lower initial minimum investment than GCLLX: RWMFX (250) vs GCLLX (1000). RWMFX annual gain was more profitable for investors over the last year : -8.19 vs. GCLLX (-8.84). GCLLX return over 5 years is better than : 48.20 vs. RWMFX (44.88).
GCLLXRWMFXGCLLX / RWMFX
Total Expense Ratio1.680.31542%
Annual Report Gross Expense Ratio2.000.31645%
Fund Existence17 years23 years-
Gain YTD-16.133-9.504170%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets352M181B0%
Annual Yield % from dividends0.001.53-
Returns for 1 year-8.84-8.19108%
Returns for 3 years5.42-2.62-207%
Returns for 5 years48.2044.88107%
Returns for 10 years17.9642.4442%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARCC20.881.97
+10.42%
Ares Capital Corp
FDMT2.760.25
+9.76%
4D Molecular Therapeutics
EVOK2.230.16
+7.73%
Evoke Pharma, Inc.
CWEN28.051.31
+4.90%
Clearway Energy
MCBS26.671.18
+4.63%
MetroCity Bankshares